Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 avr. 2015 08h50 HE | Source: Chembio Diagnostics, Inc.

Chembio Launches HIV Self-Testing Initiative in Europe

MEDFORD, N.Y., April 29, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, announced today that, for the first...
27 avr. 2015 08h50 HE | Source: Chembio Diagnostics, Inc.

Chembio to Host Conference Call to Discuss First Quarter 2015 Financial Results

MEDFORD, N.Y., April 27, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that the...
05 mars 2015 08h50 HE | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports 2014 Financial Results

MEDFORD, N.Y., March 5, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today reported financial results for the...
23 févr. 2015 08h50 HE | Source: Chembio Diagnostics, Inc.

Chembio to Host Conference Call to Discuss 2014 Financial Results

MEDFORD, N.Y., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that the...
09 févr. 2015 08h50 HE | Source: Chembio Diagnostics, Inc.

Chembio's DPP(R) HIV-Syphilis Assay Cleared for Launch in Brazil

MEDFORD, N.Y., Feb. 9, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, has received approval for commercial...
29 janv. 2015 08h50 HE | Source: Chembio Diagnostics, Inc.

Chembio Awarded Grant to Develop Next-Generation Point-of-Care Diagnostic Test for Malaria

MEDFORD, N.Y., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, has been awarded a grant from the...
22 janv. 2015 08h50 HE | Source: Chembio Diagnostics, Inc.

Chembio Acquires Rights to SURE CHECK(R) HIV 1/2 Assay Effective June 1, 2016

MEDFORD, N.Y., Jan. 22, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, has entered into an agreement with...
12 janv. 2015 08h50 HE | Source: Chembio Diagnostics, Inc.

Chembio Update on DPP(R) Ebola and DPP(R) Febrile Illness Assays

MEDFORD, N.Y., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced its progress in the...
08 janv. 2015 08h50 HE | Source: Chembio Diagnostics, Inc.

Chembio Appoints Paul Lambotte as Vice President, Product Development

MEDFORD, N.Y., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics Systems, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced the...
07 janv. 2015 08h50 HE | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics to Present at the Biotech Showcase 2015 Conference

MEDFORD, N.Y., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced that its chief executive...

Page précédente